CSF2 and cancer: M1-TAMs are classically activated through lipopolysaccharide, IFN-γ, tumor necrosis factor (TNF), GM-CSF, or Toll-like receptor (TLR) ligands, and exhibit pro-inflammatory and anti-cancer properties, releasing various cytokines [82].